ANG LIFESCIENCES INDIA LTD - Announcement under Regulation 30 (LODR)-Acquisition

ANG Lifesciences India Ltd - Announcement under Regulation 30 (LODR)-Acquisition

Download	< Back
24 Nov 2021
Pursuant to Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements), 2015, we would like to inform you that the Company's Board of Directors in their meeting held on 23-Nov-2021, has decided to invest in the equity shares of ANG Healthcare India Private Limited. Therefore consequent to the acquisition of 100% Equity stake by the company, ANG Healthcare India Private Limited will become Wholly-Owned Subsidiary Company of ANG Lifesciences India Limited.<BR> <BR> ANG Healthcare India Private Limited is a marketing company selling critical care products to Hospitals and Nursing Homes in therapeutic segments of anti-biotic, anti-infective, anti-malarial, pain management etc. The company has got presence all over India through a network of Super Stockists and 150 Stockists along with a strong sales force of about 60 personnel and expanding at a fast pace. <BR> <BR>
View all announcements for ANG Lifesciences India Ltd	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us